Phage therapy co BiomX merges with APT, raises $50m
Israeli phage therapy company BiomX (NYSE: PHGE) has announced a merger with Adaptive Phage Therapeutics (APT). The merged company is also raising $50 million in a private placement. Existing shareholders in BiomX will…
